There are three major subtypes of amyloidosis: primary amyloidosis, secondary amyloidosis, and hereditary amyloidosis (Khan & Falk, 2001; Nakata & Shimamoto, 2003; Smith, 2003). Primary ...

Amyloidosis Waldenström’s macroglobulinemia (VAHL-den-strum MA-kroh-GLAH-byoo-lih-NEE-mee-uh). Waldenström’s is a type of non-Hodgkin lymphoma that grows slowly. It’s a rare white blood cell cancer ...

Since in most cases of AL amyloidosis the plasma cell load prior to PBSCT is very low, mobilizing chemotherapy is not inevitable, although the number of collected stem cells are significantly ...

Cancer screening is crucial to early detection ... One example comes from using electrocardiogram (EKG) data to diagnose AL amyloidosis. “A particular signature of an EKG might suggest AL ...

Genmab-partnered Darzalex – which is also used to treat the blood cancer multiple myeloma – was shown in the ANDROMEDA clinical trial to delay the progression of AL amyloidosis, with 59% of ...

The U.S. observed prevalence of relapsed/refractory AL Amyloidosis is estimated to be growing at 12% per year according to Staron, et al Blood Cancer Journal, to approximately 33,277 patients in 2024.

Dr. Kara Cicero is a hematologist-oncologist focused on global oncology and cancer disparities research to advance health equity, with specific clinical expertise in multiple myeloma, AL amyloidosis ...